PP
ABCL icon

PDT Partners’s AbCellera Biologics ABCL Stock Holding History

PDT Partners’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-64,304
Closed -$143K – 678
2025
Q1 		$143K Hold
64,304
– – 0.01% 702
2024
Q4 		$188K Hold
64,304
– – 0.02% 664
2024
Q3 		$167K Sell
64,304
-173,884
-73% -$482K 0.01% 672
2024
Q2 		$705K Sell
238,188
-9,290
-4% -$35.2K 0.07% 408
2024
Q1 		$1.12M Buy
247,478
+100
+0% +$510 0.11% 310
2023
Q4 		$1.41M Buy
247,378
+37,302
+18% +$173K 0.16% 226
2023
Q3 		$966K Buy
210,076
+125,612
+149% +$764K 0.12% 291
2023
Q2 		$546K Hold
84,464
– – 0.08% 364
2023
Q1 		$637K Buy
+84,464
New +$767K 0.09% 347
2022
Q4 		– Sell
-96,417
Closed -$954K – 603
2022
Q3 		$954K Sell
96,417
-44,975
-32% -$493K 0.14% 233
2022
Q2 		$1.51M Buy
+141,392
New +$1.2M 0.13% 246

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return